ArticleMolecular and clinical oncology2023

Real-world effect of bevacizumab and eribulin on metastatic breast cancer using a propensity score matching analysis.

Koshi Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.